Skip to main content
Top
Published in: Journal of Translational Medicine 1/2014

Open Access 01-12-2014 | Research

Apoptotic function of tumor-associated antigen RCAS1 in oral squamous cell carcinoma

Authors: Hideaki Tanaka, Takeshi Toyoshima, Kenzo Sonoda, Ryoji Kitamura, Masaaki Sasaguri, Shintaro Kawano, Ryota Matsubara, Yuichi Goto, Seiji Nakamura

Published in: Journal of Translational Medicine | Issue 1/2014

Login to get access

Abstract

Background

Receptor-binding cancer antigen expressed on SiSo cell (RCAS1) is derived from uterine adenocarcinoma and can induce apoptosis in lymphocytes, allowing tumor cells to escape from immune surveillance. RCAS1 is reportedly expressed in a membranous pattern on tumor cell or soluble one in serum of patients. The aim of this study was to investigate expression patterns of RCAS1 and the effect on apoptosis in oral squamous cell carcinoma (OSCC) cell lines.

Methods

In four kinds of OSCC cell lines (HSC-2, HSC-3, SQUU-A, and SQUU-B), RCAS1 mRNAs and proteins were determined by RT-PCR and immunocytochemistry. Membranous RCAS1 was determined by flow cytometry. Culture supernatants were analyzed for detection of soluble RCAS1 by dot blotting and enzyme-linked immunosorbent assay. Apoptotic ability of RCAS1 on the erythroid leukemia cell line K562 with the putative receptor was evaluated by flow cytometry in co-culture with highly metastatic SQUU-B, with knocked-down RCAS1 cells or in a no-cell contact condition.

Results

RCAS1 mRNA and proteins were expressed in all of OSCC cell lines. Membranous pattern were expressed in all cell lines, while soluble pattern was detected in all supernatants. RCAS1 mRNA, membranous and soluble RCAS1 were significantly seen in SQUU-B more than the other 3 cell lines (P < 0.05). K562 apoptosis was induced in co-culture with each of all cell lines, particularly with SQUU-B. Apoptosis was markedly reduced in co-culture with RCAS1 knockdown cells, but was induced in co-culture without cell contract of SQUU-B.

Conlusions

Our study suggests that RCAS1 has an apoptotic function via membranous/soluble expression pattern in OSCC cells. RCAS1 may thus affect tumor escape from immune surveillance in OSCC by inducing apoptosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sonoda K, Nakashima M, Saito T, Amada S, Kamura T, Nakano H, Watanabe T: Establishment of a new human uterine cervical adenocarcinoma cell-line, siso, and its reactivity to anticancer reagents. Int J Oncol. 1995, 6: 1099-1104.PubMed Sonoda K, Nakashima M, Saito T, Amada S, Kamura T, Nakano H, Watanabe T: Establishment of a new human uterine cervical adenocarcinoma cell-line, siso, and its reactivity to anticancer reagents. Int J Oncol. 1995, 6: 1099-1104.PubMed
2.
go back to reference Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T: A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer. 1996, 77: 1501-1509. 10.1002/(SICI)1097-0142(19960415)77:8<1501::AID-CNCR12>3.0.CO;2-3.CrossRefPubMed Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T: A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer. 1996, 77: 1501-1509. 10.1002/(SICI)1097-0142(19960415)77:8<1501::AID-CNCR12>3.0.CO;2-3.CrossRefPubMed
3.
go back to reference Sonoda K, Miyamoto S, Yotsumoto F, Yagi H, Nakashima M, Watanabe T, Nakano H: Clinical significance of RCAS1 as a biomarker of ovarian cancer. Oncol Rep. 2007, 17: 623-628.PubMed Sonoda K, Miyamoto S, Yotsumoto F, Yagi H, Nakashima M, Watanabe T, Nakano H: Clinical significance of RCAS1 as a biomarker of ovarian cancer. Oncol Rep. 2007, 17: 623-628.PubMed
4.
go back to reference Iwasaki T, Nakashima M, Watanabe T, Yamamoto S, Inoue Y, Yamanaka H, Matsumura A, Iuchi K, Mori T, Okada M: Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. Int J Cancer. 2000, 89: 488-493. 10.1002/1097-0215(20001120)89:6<488::AID-IJC4>3.0.CO;2-D.CrossRefPubMed Iwasaki T, Nakashima M, Watanabe T, Yamamoto S, Inoue Y, Yamanaka H, Matsumura A, Iuchi K, Mori T, Okada M: Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1. Int J Cancer. 2000, 89: 488-493. 10.1002/1097-0215(20001120)89:6<488::AID-IJC4>3.0.CO;2-D.CrossRefPubMed
5.
go back to reference Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T, Nakano H: The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Gynecol Oncol. 2000, 79: 424-429. 10.1006/gyno.2000.5981.CrossRefPubMed Sonoda K, Kaku T, Hirakawa T, Kobayashi H, Amada S, Sakai K, Nakashima M, Watanabe T, Nakano H: The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. Gynecol Oncol. 2000, 79: 424-429. 10.1006/gyno.2000.5981.CrossRefPubMed
6.
go back to reference Umeoka K, Sanno N, Oyama K, Tahara S, Kurotani R, Ikuyama S, Nakashima M, Watanabe T, Osamura RY, Teramoto A: Immunohistochemical analysis of RCAS1 in human pituitary adenomas. Mod Pathol. 2001, 14: 1232-1236. 10.1038/modpathol.3880467.CrossRefPubMed Umeoka K, Sanno N, Oyama K, Tahara S, Kurotani R, Ikuyama S, Nakashima M, Watanabe T, Osamura RY, Teramoto A: Immunohistochemical analysis of RCAS1 in human pituitary adenomas. Mod Pathol. 2001, 14: 1232-1236. 10.1038/modpathol.3880467.CrossRefPubMed
7.
go back to reference Hiraoka K, Hida Y, Miyamoto M, Oshikiri T, Suzuoki M, Nakakubo Y, Shinohara T, Itoh T, Shichinohe T, Kondo S, Kasahara N, Katoh H: High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker. Int J Cancer. 2002, 99: 418-423. 10.1002/ijc.10381.CrossRefPubMed Hiraoka K, Hida Y, Miyamoto M, Oshikiri T, Suzuoki M, Nakakubo Y, Shinohara T, Itoh T, Shichinohe T, Kondo S, Kasahara N, Katoh H: High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker. Int J Cancer. 2002, 99: 418-423. 10.1002/ijc.10381.CrossRefPubMed
8.
go back to reference Oizumi S, Yamazaki K, Nakashima M, Watanabe T, Hommura F, Ogura S, Nishimura M, Dosaka-Akita H: RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lung. Oncology. 2002, 62: 333-339. 10.1159/000065065.CrossRefPubMed Oizumi S, Yamazaki K, Nakashima M, Watanabe T, Hommura F, Ogura S, Nishimura M, Dosaka-Akita H: RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lung. Oncology. 2002, 62: 333-339. 10.1159/000065065.CrossRefPubMed
9.
go back to reference Akashi T, Oimomi H, Nishiyama K, Nakashima M, Arita Y, Sumii T, Kimura T, Ito T, Nawata H, Watanabe T: Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer. Pancreas. 2003, 26: 49-55. 10.1097/00006676-200301000-00009.CrossRefPubMed Akashi T, Oimomi H, Nishiyama K, Nakashima M, Arita Y, Sumii T, Kimura T, Ito T, Nawata H, Watanabe T: Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer. Pancreas. 2003, 26: 49-55. 10.1097/00006676-200301000-00009.CrossRefPubMed
10.
go back to reference Okada K, Nakashima M, Komuta K, Hashimoto S, Okudaira S, Baba N, Hishikawa Y, Koji T, Kanematsu T, Watanabe T: Expression of tumor-associated membrane antigen, RCAS1, in human colorectal carcinomas and possible role in apoptosis of tumor-infiltrating lymphocytes. Mod Pathol. 2003, 16: 679-685. 10.1097/01.MP.0000074732.17945.6C.CrossRefPubMed Okada K, Nakashima M, Komuta K, Hashimoto S, Okudaira S, Baba N, Hishikawa Y, Koji T, Kanematsu T, Watanabe T: Expression of tumor-associated membrane antigen, RCAS1, in human colorectal carcinomas and possible role in apoptosis of tumor-infiltrating lymphocytes. Mod Pathol. 2003, 16: 679-685. 10.1097/01.MP.0000074732.17945.6C.CrossRefPubMed
11.
go back to reference Sonoda K, Miyamoto S, Hirakawa T, Kaku T, Nakashima M, Watanabe T, Akazawa K, Fujita T, Nakano H: Association between RCAS1 expression and clinical outcome in uterine endometrial cancer. Br J Cancer. 2003, 89: 546-551. 10.1038/sj.bjc.6601126.PubMedCentralCrossRefPubMed Sonoda K, Miyamoto S, Hirakawa T, Kaku T, Nakashima M, Watanabe T, Akazawa K, Fujita T, Nakano H: Association between RCAS1 expression and clinical outcome in uterine endometrial cancer. Br J Cancer. 2003, 89: 546-551. 10.1038/sj.bjc.6601126.PubMedCentralCrossRefPubMed
12.
go back to reference Muta K, Ohshima K, Abe Y, Uike N, Choi I, Matsushima T, Nishimura J, Kikuchi M, Nakashima M, Watanabe T, Nawata H: Expression of human tumor-associated antigen RCAS1 in adult T-cell leukemia/lymphoma. Int J Hematol. 2004, 79: 340-344. 10.1532/IJH97.03109.CrossRefPubMed Muta K, Ohshima K, Abe Y, Uike N, Choi I, Matsushima T, Nishimura J, Kikuchi M, Nakashima M, Watanabe T, Nawata H: Expression of human tumor-associated antigen RCAS1 in adult T-cell leukemia/lymphoma. Int J Hematol. 2004, 79: 340-344. 10.1532/IJH97.03109.CrossRefPubMed
13.
go back to reference Nakamura Y, Yamazaki K, Oizumi S, Nakashima M, Watanabe T, Dosaka-Akita H, Nishimura M: Expression of RCAS1 in human gastric carcinoma: a potential mechanism of immune escape. Cancer Sci. 2004, 95: 260-265. 10.1111/j.1349-7006.2004.tb02213.x.CrossRefPubMed Nakamura Y, Yamazaki K, Oizumi S, Nakashima M, Watanabe T, Dosaka-Akita H, Nishimura M: Expression of RCAS1 in human gastric carcinoma: a potential mechanism of immune escape. Cancer Sci. 2004, 95: 260-265. 10.1111/j.1349-7006.2004.tb02213.x.CrossRefPubMed
14.
go back to reference Leelawat K, Engprasert S, Tujinda S, Suthippintawong C, Enjoji M, Nakashima M, Watanabe T, Leardkamolkarn V: Receptor-binding cancer antigen expressed on SiSo cells can be detected in metastatic lymph nodes from gastrointestinal cancers. World J Gastroenterol. 2005, 11: 6014-6017.PubMedCentralCrossRefPubMed Leelawat K, Engprasert S, Tujinda S, Suthippintawong C, Enjoji M, Nakashima M, Watanabe T, Leardkamolkarn V: Receptor-binding cancer antigen expressed on SiSo cells can be detected in metastatic lymph nodes from gastrointestinal cancers. World J Gastroenterol. 2005, 11: 6014-6017.PubMedCentralCrossRefPubMed
15.
go back to reference Coban S, Ozkan H, Koklu S, Yuksel O, Kockar MC, Akar T, Ormeci N: The utility of serum receptor-binding cancer antigen expressed on SiSo cells in gastrointestinal tract cancers. Can J Gastroenterol. 2006, 20: 593-596.PubMedCentralPubMed Coban S, Ozkan H, Koklu S, Yuksel O, Kockar MC, Akar T, Ormeci N: The utility of serum receptor-binding cancer antigen expressed on SiSo cells in gastrointestinal tract cancers. Can J Gastroenterol. 2006, 20: 593-596.PubMedCentralPubMed
16.
go back to reference Kohri T, Sugano M, Kawashima O, Saito R, Sakurai S, Sano T, Nakajima T: Prognostic model of stage II non-small cell lung cancer by a discriminant analysis of the immunohistochemical protein expression. Surg Today. 2006, 36: 1039-1046. 10.1007/s00595-006-3319-1.CrossRefPubMed Kohri T, Sugano M, Kawashima O, Saito R, Sakurai S, Sano T, Nakajima T: Prognostic model of stage II non-small cell lung cancer by a discriminant analysis of the immunohistochemical protein expression. Surg Today. 2006, 36: 1039-1046. 10.1007/s00595-006-3319-1.CrossRefPubMed
17.
go back to reference Tsujitani S, Saito H, Oka S, Sakamoto T, Kanaji S, Tatebe S, Ikeguchi M: Prognostic significance of RCAS1 expression in relation to the infiltration of dendritic cells and lymphocytes in patients with esophageal carcinoma. Dig Dis Sci. 2007, 52: 549-554. 10.1007/s10620-006-9408-6.CrossRefPubMed Tsujitani S, Saito H, Oka S, Sakamoto T, Kanaji S, Tatebe S, Ikeguchi M: Prognostic significance of RCAS1 expression in relation to the infiltration of dendritic cells and lymphocytes in patients with esophageal carcinoma. Dig Dis Sci. 2007, 52: 549-554. 10.1007/s10620-006-9408-6.CrossRefPubMed
18.
go back to reference Giaginis C, Davides D, Zarros A, Noussia O, Zizi-Serbetzoglou A, Kouraklis G, Theocharis S: Clinical significance of tumor-associated antigen RCAS1 expression in human pancreatic ductal adenocarcinoma. Dig Dis Sci. 2008, 53: 1728-1734. 10.1007/s10620-007-0035-7.CrossRefPubMed Giaginis C, Davides D, Zarros A, Noussia O, Zizi-Serbetzoglou A, Kouraklis G, Theocharis S: Clinical significance of tumor-associated antigen RCAS1 expression in human pancreatic ductal adenocarcinoma. Dig Dis Sci. 2008, 53: 1728-1734. 10.1007/s10620-007-0035-7.CrossRefPubMed
19.
go back to reference Yang YC, Zhao YP, Liao Q, Zhang TP, Hu Y, Dai MH: Evaluation of RCAS1 as serum tumor marker for pancreatic cancer. Zhonghua Wai Ke Za Zhi. 2009, 47: 999-1001.PubMed Yang YC, Zhao YP, Liao Q, Zhang TP, Hu Y, Dai MH: Evaluation of RCAS1 as serum tumor marker for pancreatic cancer. Zhonghua Wai Ke Za Zhi. 2009, 47: 999-1001.PubMed
20.
go back to reference Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, Tsourouflis G, Sastre-Garau X: RCAS1 expression in mobile tongue squamous cell carcinoma: an immunohistochemical study. Med Sci Monit. 2011, 17: Br228-Br234.PubMedCentralCrossRefPubMed Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, Tsourouflis G, Sastre-Garau X: RCAS1 expression in mobile tongue squamous cell carcinoma: an immunohistochemical study. Med Sci Monit. 2011, 17: Br228-Br234.PubMedCentralCrossRefPubMed
21.
go back to reference Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med. 1999, 5: 938-942. 10.1038/11383.CrossRefPubMed Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med. 1999, 5: 938-942. 10.1038/11383.CrossRefPubMed
22.
go back to reference Sonoda K, Miyamoto S, Nakashima M, Wake N: Receptor-binding cancer antigen expressed on SiSo cells induces apoptosis via ectodomain shedding. Exp Cell Res. 2010, 316: 1795-1803. 10.1016/j.yexcr.2010.01.011.CrossRefPubMed Sonoda K, Miyamoto S, Nakashima M, Wake N: Receptor-binding cancer antigen expressed on SiSo cells induces apoptosis via ectodomain shedding. Exp Cell Res. 2010, 316: 1795-1803. 10.1016/j.yexcr.2010.01.011.CrossRefPubMed
23.
go back to reference Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Clinical significance of RCAS1 as a biomarker of uterine cancer. Gynecol Oncol. 2006, 103: 924-931. 10.1016/j.ygyno.2006.05.047.CrossRefPubMed Sonoda K, Miyamoto S, Hirakawa T, Yagi H, Yotsumoto F, Nakashima M, Watanabe T, Nakano H: Clinical significance of RCAS1 as a biomarker of uterine cancer. Gynecol Oncol. 2006, 103: 924-931. 10.1016/j.ygyno.2006.05.047.CrossRefPubMed
24.
go back to reference Giaginis C, Giagini A, Theocharis S: Recepter-binding cancer antigen expressed on SiSo cells (RCAS1): a novel biomarker in the diagnosis and pregnosis of human neoplasia. Histol Histopathol. 2009, 24: 761-776.PubMed Giaginis C, Giagini A, Theocharis S: Recepter-binding cancer antigen expressed on SiSo cells (RCAS1): a novel biomarker in the diagnosis and pregnosis of human neoplasia. Histol Histopathol. 2009, 24: 761-776.PubMed
25.
go back to reference Toyoshima T, Nakamura S, Kumamaru W, Kawamura E, Ishibashi H, Hayashida JN, Moriyama M, Ohyama Y, Sasaki M, Shirasuna K: Expression of tumor-associated antigen RCAS1 and its possible involvement in immune evasion in oral squamous cell carcinoma. J Oral Pathol Med. 2006, 35: 361-368. 10.1111/j.1600-0714.2006.00442.x.CrossRefPubMed Toyoshima T, Nakamura S, Kumamaru W, Kawamura E, Ishibashi H, Hayashida JN, Moriyama M, Ohyama Y, Sasaki M, Shirasuna K: Expression of tumor-associated antigen RCAS1 and its possible involvement in immune evasion in oral squamous cell carcinoma. J Oral Pathol Med. 2006, 35: 361-368. 10.1111/j.1600-0714.2006.00442.x.CrossRefPubMed
26.
go back to reference Tsai TC, Yu CH, Cheng SJ, Liu BY, Chen HM, Chiang CP: Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Oral Oncol. 2008, 44: 759-766. 10.1016/j.oraloncology.2007.08.020.CrossRefPubMed Tsai TC, Yu CH, Cheng SJ, Liu BY, Chen HM, Chiang CP: Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Oral Oncol. 2008, 44: 759-766. 10.1016/j.oraloncology.2007.08.020.CrossRefPubMed
27.
go back to reference Momose F, Araida T, Negishi A, Ichijo H, Shioda S, Sasaki S: Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas. J Oral Pathol Med. 1989, 18: 391-395. 10.1111/j.1600-0714.1989.tb01570.x.CrossRefPubMed Momose F, Araida T, Negishi A, Ichijo H, Shioda S, Sasaki S: Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas. J Oral Pathol Med. 1989, 18: 391-395. 10.1111/j.1600-0714.1989.tb01570.x.CrossRefPubMed
28.
go back to reference Morifuji M, Taniguchi S, Sakai H, Nakabeppu Y, Ohishi M: Differential expression of cytokeratin after orthotopic implantation of newly established human tongue cancer cell lines of defined metastatic ability. Am J Pathol. 2000, 156: 1317-1326. 10.1016/S0002-9440(10)65002-X.PubMedCentralCrossRefPubMed Morifuji M, Taniguchi S, Sakai H, Nakabeppu Y, Ohishi M: Differential expression of cytokeratin after orthotopic implantation of newly established human tongue cancer cell lines of defined metastatic ability. Am J Pathol. 2000, 156: 1317-1326. 10.1016/S0002-9440(10)65002-X.PubMedCentralCrossRefPubMed
29.
go back to reference Tsuneizumi M, Emi M, Nagai H, Harada H, Sakamoto G, Kasumi F, Inoue S, Kazui T, Nakamura Y: Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers. Clin Cancer Res. 2001, 7: 3526-3532.PubMed Tsuneizumi M, Emi M, Nagai H, Harada H, Sakamoto G, Kasumi F, Inoue S, Kazui T, Nakamura Y: Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers. Clin Cancer Res. 2001, 7: 3526-3532.PubMed
30.
go back to reference Enjoji M, Nakashima M, Nishi H, Choi I, Oimomi H, Sugimoto R, Kotoh K, Taguchi K, Nakamuta M, Nawata H, Watanabe T: The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of biliary tract. J Hepatol. 2002, 36: 786-792. 10.1016/S0168-8278(02)00066-1.CrossRefPubMed Enjoji M, Nakashima M, Nishi H, Choi I, Oimomi H, Sugimoto R, Kotoh K, Taguchi K, Nakamuta M, Nawata H, Watanabe T: The tumor-associated antigen, RCAS1, can be expressed in immune-mediated diseases as well as in carcinomas of biliary tract. J Hepatol. 2002, 36: 786-792. 10.1016/S0168-8278(02)00066-1.CrossRefPubMed
31.
go back to reference Rousseau J, Tetu B, Caron D, Malenfant P, Cattaruzzi P, Audette M, Doillon C, Tremblay JP, Guerette B: RCAS1 is associated with ductal breast cancer progression. Biochem Biophys Res Commun. 2002, 293: 1544-1549. 10.1016/S0006-291X(02)00401-1.CrossRefPubMed Rousseau J, Tetu B, Caron D, Malenfant P, Cattaruzzi P, Audette M, Doillon C, Tremblay JP, Guerette B: RCAS1 is associated with ductal breast cancer progression. Biochem Biophys Res Commun. 2002, 293: 1544-1549. 10.1016/S0006-291X(02)00401-1.CrossRefPubMed
32.
go back to reference Reimer TA, Anagnostopoulos I, Erdmann B, Lehmann I, Stein H, Daniel P, Dorken B, Rehm A: Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker. BMC Cancer. 2005, 5: 47-10.1186/1471-2407-5-47.PubMedCentralCrossRefPubMed Reimer TA, Anagnostopoulos I, Erdmann B, Lehmann I, Stein H, Daniel P, Dorken B, Rehm A: Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker. BMC Cancer. 2005, 5: 47-10.1186/1471-2407-5-47.PubMedCentralCrossRefPubMed
33.
go back to reference Leelawat K, Watanabe T, Nakajima M, Tujinda S, Suthipintawong C, Leardkamolkarn V: Upregulation of tumour associated antigen RCAS1 is implicated in high stages of colorectal cancer. J Clin Pathol. 2003, 56: 764-768. 10.1136/jcp.56.10.764.PubMedCentralCrossRefPubMed Leelawat K, Watanabe T, Nakajima M, Tujinda S, Suthipintawong C, Leardkamolkarn V: Upregulation of tumour associated antigen RCAS1 is implicated in high stages of colorectal cancer. J Clin Pathol. 2003, 56: 764-768. 10.1136/jcp.56.10.764.PubMedCentralCrossRefPubMed
34.
go back to reference Giaginis C, Margeli A, Kouraklis G, Zira A, Tsourouflis G, Theocharis S: Diagnostic and prognostic utility of serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) levels in colon cancer patients. Int J Biol Markers. 2009, 24: 70-76.PubMed Giaginis C, Margeli A, Kouraklis G, Zira A, Tsourouflis G, Theocharis S: Diagnostic and prognostic utility of serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) levels in colon cancer patients. Int J Biol Markers. 2009, 24: 70-76.PubMed
35.
go back to reference Sonoda K, Miyamoto S, Kobayashi H, Ogawa S, Okugawa K, Taniguchi S, Wake N: The level of RCAS1 expression is inversely correlated with the number of vimentin-positive stromal cells in epithelial ovarian cancer. Int J Gynecol Cancer. 2009, 19: 838-843. 10.1111/IGC.0b013e3181a5ff6a.CrossRefPubMed Sonoda K, Miyamoto S, Kobayashi H, Ogawa S, Okugawa K, Taniguchi S, Wake N: The level of RCAS1 expression is inversely correlated with the number of vimentin-positive stromal cells in epithelial ovarian cancer. Int J Gynecol Cancer. 2009, 19: 838-843. 10.1111/IGC.0b013e3181a5ff6a.CrossRefPubMed
36.
go back to reference Sonoda K, Miyamoto S, Yamazaki A, Kobayashi H, Nakashima M, Mekada E, Wake N: Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer. Cancer. 2007, 110: 1979-1990. 10.1002/cncr.23015.CrossRefPubMed Sonoda K, Miyamoto S, Yamazaki A, Kobayashi H, Nakashima M, Mekada E, Wake N: Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer. Cancer. 2007, 110: 1979-1990. 10.1002/cncr.23015.CrossRefPubMed
Metadata
Title
Apoptotic function of tumor-associated antigen RCAS1 in oral squamous cell carcinoma
Authors
Hideaki Tanaka
Takeshi Toyoshima
Kenzo Sonoda
Ryoji Kitamura
Masaaki Sasaguri
Shintaro Kawano
Ryota Matsubara
Yuichi Goto
Seiji Nakamura
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2014
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-12-112

Other articles of this Issue 1/2014

Journal of Translational Medicine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.